CN106389651A - 一种内服外敷用于促进神经外科术后康复的儿童中药 - Google Patents
一种内服外敷用于促进神经外科术后康复的儿童中药 Download PDFInfo
- Publication number
- CN106389651A CN106389651A CN201611078822.7A CN201611078822A CN106389651A CN 106389651 A CN106389651 A CN 106389651A CN 201611078822 A CN201611078822 A CN 201611078822A CN 106389651 A CN106389651 A CN 106389651A
- Authority
- CN
- China
- Prior art keywords
- grams
- chinese medicine
- vinegar
- myrrh
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 153
- 230000002980 postoperative effect Effects 0.000 title claims abstract description 36
- 230000001737 promoting effect Effects 0.000 title claims abstract description 26
- 241000218176 Corydalis Species 0.000 claims abstract description 46
- 239000000052 vinegar Substances 0.000 claims abstract description 46
- 235000021419 vinegar Nutrition 0.000 claims abstract description 46
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 40
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 40
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 40
- 240000004274 Sarcandra glabra Species 0.000 claims abstract description 40
- 235000014290 Artemisia anomala Nutrition 0.000 claims abstract description 31
- 241000123844 Artemisia anomala Species 0.000 claims abstract description 31
- 244000105624 Arachis hypogaea Species 0.000 claims abstract description 30
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 30
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 30
- 235000020232 peanut Nutrition 0.000 claims abstract description 30
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 claims abstract description 25
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims abstract description 21
- 102000002322 Egg Proteins Human genes 0.000 claims abstract description 21
- 108010000912 Egg Proteins Proteins 0.000 claims abstract description 21
- 235000014103 egg white Nutrition 0.000 claims abstract description 21
- 210000000969 egg white Anatomy 0.000 claims abstract description 21
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 20
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 20
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 20
- 229940116229 borneol Drugs 0.000 claims abstract description 20
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 20
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 20
- 241000405414 Rehmannia Species 0.000 claims abstract description 19
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 11
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 4
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 4
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 4
- 235000011477 liquorice Nutrition 0.000 claims abstract description 4
- 239000000203 mixture Substances 0.000 claims description 76
- 239000000463 material Substances 0.000 claims description 37
- 239000000706 filtrate Substances 0.000 claims description 33
- 239000000865 liniment Substances 0.000 claims description 33
- 229940040145 liniment Drugs 0.000 claims description 33
- 235000017060 Arachis glabrata Nutrition 0.000 claims description 29
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 29
- 235000018262 Arachis monticola Nutrition 0.000 claims description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- 238000002360 preparation method Methods 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 20
- 244000246386 Mentha pulegium Species 0.000 claims description 19
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 19
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 19
- 240000007164 Salvia officinalis Species 0.000 claims description 19
- 235000001050 hortel pimenta Nutrition 0.000 claims description 19
- 235000005412 red sage Nutrition 0.000 claims description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 17
- 238000003756 stirring Methods 0.000 claims description 17
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 15
- 239000000284 extract Substances 0.000 claims description 14
- 238000001914 filtration Methods 0.000 claims description 13
- 235000021552 granulated sugar Nutrition 0.000 claims description 13
- 238000009835 boiling Methods 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 11
- 241000245665 Taraxacum Species 0.000 claims description 10
- 239000000341 volatile oil Substances 0.000 claims description 9
- 235000000346 sugar Nutrition 0.000 claims description 8
- 206010053615 Thermal burn Diseases 0.000 claims description 6
- 239000000469 ethanolic extract Substances 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 239000004576 sand Substances 0.000 claims description 6
- 239000011505 plaster Substances 0.000 claims description 5
- 239000006188 syrup Substances 0.000 claims description 5
- 235000020357 syrup Nutrition 0.000 claims description 5
- 241000213006 Angelica dahurica Species 0.000 claims description 4
- 239000002002 slurry Substances 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 3
- 238000004821 distillation Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 235000012054 meals Nutrition 0.000 claims description 3
- 238000005325 percolation Methods 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 238000007598 dipping method Methods 0.000 claims description 2
- 244000061520 Angelica archangelica Species 0.000 claims 2
- 238000000605 extraction Methods 0.000 claims 1
- 239000004744 fabric Substances 0.000 claims 1
- 239000002893 slag Substances 0.000 claims 1
- 208000002193 Pain Diseases 0.000 abstract description 29
- 230000000694 effects Effects 0.000 abstract description 17
- 239000008280 blood Substances 0.000 abstract description 5
- 210000004369 blood Anatomy 0.000 abstract description 5
- 210000003205 muscle Anatomy 0.000 abstract description 4
- 238000011084 recovery Methods 0.000 abstract description 4
- 238000010792 warming Methods 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
- 229930006000 Sucrose Natural products 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 238000005728 strengthening Methods 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 abstract 1
- 235000012141 vanillin Nutrition 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 17
- 241000125175 Angelica Species 0.000 description 13
- 206010052428 Wound Diseases 0.000 description 13
- 208000027418 Wounds and injury Diseases 0.000 description 13
- 241001465754 Metazoa Species 0.000 description 12
- 241000699666 Mus <mouse, genus> Species 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 206010039509 Scab Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 210000004556 brain Anatomy 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 210000000278 spinal cord Anatomy 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 208000031650 Surgical Wound Infection Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 210000001259 mesencephalon Anatomy 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 235000021049 nutrient content Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 210000000578 peripheral nerve Anatomy 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 231100000111 LD50 Toxicity 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 238000011887 Necropsy Methods 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 206010039203 Road traffic accident Diseases 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- YLRFCQOZQXIBAB-RBZZARIASA-N fluoxymesterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1CC[C@](C)(O)[C@@]1(C)C[C@@H]2O YLRFCQOZQXIBAB-RBZZARIASA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000007923 nasal drop Substances 0.000 description 1
- 229940100662 nasal drops Drugs 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 150000002814 niacins Chemical class 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 210000001428 peripheral nervous system Anatomy 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000002360 prefrontal effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000012976 tarts Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 210000004885 white matter Anatomy 0.000 description 1
- 239000009306 yunnan baiyao Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Physiology (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Insects & Arthropods (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种内服外敷用于促进神经外科术后康复的儿童中药,内服药物按下列和重量的中药原料组成:甘草42克、薄荷22克、肿节风33克、刘寄奴22克、没药18克、红花33克、丹参21克、地黄29克、白芷32克、延胡索17克、蜂房42克、蒲公英28克、皂角刺34克、忍冬藤57克、醋175克、花生175克、蛋清64克、香兰素0.075克以及白砂糖45克;外敷药物按下列和重量的中药原料组成:肿节风33克、刘寄奴22克、没药18克、红花33克、延胡索17克、北沙参42克、川芎27克、柴胡36克、冰片55克、醋175克,可加快术后康复、温经散寒、强筋活血、通络止痛效果,是神经外科术后康复特效中药,未出现毒副作用,有效率达95%,治愈率85%。
Description
技术领域
本发明涉及神经外科领域,具体涉及一种内服外敷用于促进神经外科术后康复的儿童中药。
背景技术
神经外科手术的起源得追溯到1935年,当时,葡萄牙精神病学家Moniz和神经外科医师Lima合作,施行双侧前额叶脑白质切除手术,开创了精神外科学,并将该手术命名为"Moniz-Lima"手术。这种手术可以令躁狂型的精神分裂症病人变得温顺,冲动攻击行为明显减少,在北美和欧洲医学界风靡一时,它的发明者也因此获得1949年诺贝尔生物与医学奖。
神经外科是以手术为主要手段,医治中枢神经系统(脑、脊髓)、周围神经系统和植物神经系统疾病的一门临床外科专科,是外科学中的一个分支,是在外科学以手术为主要治疗手段的基础上,应用独特的神经外科学研究方法,研究人体神经系统,如脑、脊髓和周围神经系统,以及与之相关的附属机构,如颅骨、头皮、脑血管脑膜等结构的损伤、炎症、肿瘤、畸形和某些遗传代谢障碍或功能紊乱疾病,如:癫痫、帕金森病、神经痛等疾病的病因及发病机制,并探索新的诊断、治疗、预防技术的一门高、精、尖学科。
神经外科是主治由于外伤导致的脑部、脊髓等神经系统的疾病,例如脑出血出血量危及生命,车祸致脑部外伤,或脑部有肿瘤压迫需手术治疗等。手术在临床上是治疗疾病和外伤的重要手段,外科手术容易发生伤口感染,目前临床上多以服用具有消炎作用的西药为预防手段。目前对手术后的刀口和一些刀伤,除了缝合伤口和常规治疗手段外,一般采用的方法是输液打针吃药,一周需要上千元,患者不但要承受精神和肉体上的痛苦,还要承受昂贵的治疗药费的经济负担。除此之外一般采用的方法是抗生素治疗,药品使用的频率越高,耐药情况的出现就越快,对患者身体健康极为不利。目前,用于外伤的中药复方有云南白药、桃花散、圣金刀散等。用于止血的外伤药目前主要是云南白药,原名叫“百宝丹”,是曲焕章于1902年研制成功的,距今已有百年历史。
目前市场上一种促进神经外科术后康复的中药的中药制剂种类繁多,但是大多数存在着见效慢、疗程长、容易复发等缺点,给患者带来较大的痛苦和不便、且没有针对儿童的中药,全部都是针对成人的中药,所以亟需改进。
发明内容
本发明的目的提供一种内服外敷用于促进神经外科术后康复的儿童中药,解决上述现有技术问题中的一个或者多个。
本发明一个方面提供,一种内服外敷用于促进神经外科术后康复的儿童中药,包括内服药物和外敷药物;
内服药物按下列和重量的中药原料组成:甘草35~50克、薄荷15~30克、肿节风20~45克、刘寄奴15~30克、没药10~25克、红花20~45克、丹参15~27克、地黄20~40克、白芷20~45克、延胡索10~25克、蜂房35~50克、蒲公英20~35克、皂角刺20~45克、忍冬藤40~70克、醋150~200克、花生150~200克、蛋清40~80克、香兰素0.05-0.1克以及白砂糖30~60克;
外敷药物按下列和重量的中药原料组成:肿节风20~45克、刘寄奴15~30克、没药10~25克、红花20~45克、延胡索10~25克、北沙参35~50克、川芎20~35克、柴胡20~45克、冰片40~70克、醋150~200克。
在一些实施方式中,包括内服药物和外敷药物;内服药物按下列和重量的中药原料组成:甘草40~45克、薄荷20~25克、肿节风25~40克、刘寄奴20~25克、没药15~20克、红花25~40克、丹参18~24克、地黄25~35克、白芷25~40克、延胡索15~20克、蜂房40~45克、蒲公英25~30克、皂角刺25~40克、忍冬藤45~65克、醋160~190克、花生160~190克、蛋清50~70克、香兰素0.06-0.9克以及白砂糖35~55克;
外敷药物按下列和重量的中药原料组成:肿节风25~40克、刘寄奴20~25克、没药15~20克、红花25~40克、延胡索15~20克、北沙参40~45克、川芎25~30克、柴胡25~40克、冰片50~60克、醋160~190克。
在一些实施方式中,包括内服药物和外敷药物;内服药物按下列和重量的中药原料组成:甘草41~43克、薄荷21~23克、肿节风30~35克、刘寄奴21~23克、没药17~19克、红花30~35克、丹参20~22克、地黄28~30克、白芷27~35克、延胡索16~18克、蜂房41~43克、蒲公英27~29克、皂角刺33~35克、忍冬藤55~60克、醋170~180克、花生170~180克、蛋清60~66克、香兰素0.07-0.8克以及白砂糖40~50克;
外敷药物按下列和重量的中药原料组成:肿节风30~35克、刘寄奴21~23克、没药17~19克、红花30~35克、延胡索16~18克、北沙参41~43克、川芎26~28克、柴胡35~38克、冰片52~57克、醋170~180克。
在一些实施方式中,包括内服药物和外敷药物;内服药物按下列和重量的中药原料组成:甘草42克、薄荷22克、肿节风33克、刘寄奴22克、没药18克、红花33克、丹参21克、地黄29克、白芷32克、延胡索17克、蜂房42克、蒲公英28克、皂角刺34克、忍冬藤57克、醋175克、花生175克、蛋清64克、香兰素0.075克以及白砂糖45克;
外敷药物按下列和重量的中药原料组成:肿节风33克、刘寄奴22克、没药18克、红花33克、延胡索17克、北沙参42克、川芎27克、柴胡36克、冰片55克、醋175克。
本发明另一个方面提供,内服药物的制备方法和外敷药物的制备方法:
内服药物的制备方法包括以下步骤:
步骤一:取甘草、肿节风、没药、刘寄奴和红花混合均匀,加6~9倍量水,加热回流3~4h、蒸馏,收集第一次蒸馏液后,再次蒸馏1~2h,收集第二次蒸馏液后,合并第一次蒸馏液和第二次蒸馏液,提取挥发油,得到挥发油;
步骤二:取丹参、地黄、白芷和蒲公英混合均匀,加6~8倍量水微沸煎煮1~2h,滤过,滤渣再加3~6倍量水微沸煎煮40~60min,滤过,合并滤液,提取滤液,得到第一滤液;
步骤三:取皂角刺、忍冬藤和薄荷混合均匀,粉碎成粗粉,按渗漉法制备,用50~70%乙醇作溶剂,浸渍20~35h后,缓缓渗漉,待有效成分完全漉出,收集漉液,回收乙醇,提取漉液,得到第一漉液;
步骤四:取延胡索及醋,将醋中加入水后,加入延胡索烫至微沸,滤过,提取滤液,得第二滤液;
步骤五:合并步骤二中提取的第一滤液、步骤三中提取的第一漉液以及步骤四中提取的第二滤液,静置8~10h,滤过,放置温度至15~20℃,加入步骤一中提取的挥发油,加入2~4倍量的水,搅匀,得到第一混合物;
步骤六:取蛋清、白砂糖及蜂房放入锅里,加热搅拌,一直搅拌到变为浆为止,制成糖浆;
步骤七:将步骤五中得到的第一混合物放入步骤六中制成的糖浆中搅拌均匀成为第二混合物;将第二混合物中加入香兰素,混合均匀,得到第三混合物;
步骤八:取花生倒入步骤七中制得的第三混合物中,搅拌至第三混合物包裹在花生外皮上,继续搅拌,直到温度变凉,得到成品;
外敷药物的制备方法包括以下步骤:
步骤一:分别粉碎,再和北沙参、川芎、柴胡、冰片一起放入1650ml质量浓度为50%以上的乙醇中浸泡15天,过滤,得乙醇提取液;
步骤二:药渣再加水2200ml,煎煮1h,过滤,得水煎液,浓缩至160ml,制的第一滤液;
步骤三:取延胡索及醋,将醋中加入水后,加入延胡索烫至微沸,滤过,提取滤液,得第二滤液;
步骤四:混合步骤一中制得的乙醇提取液、步骤二中制得的第一滤液以及步骤三中制得的第二滤液,混合均匀,再加热浓缩至220ml,得中药浸膏;
步骤五:将肿节风、刘寄奴、没药、红花分别粉碎,混合成中药粉,将步骤四中制得的中药浸膏加入中药粉中,拌匀,摊在贴布上切成小块即成中药贴;每贴为5×5cm的贴布上摊有6ml中药浸膏和3g中药粉,制的成品。
本发明提供的一种内服外敷用于促进神经外科术后康复的儿童中药,选用多种对神经外科术后康复有针对性成分的中药起相互协同作用,同时加入花生、香兰素为辅料,更有利于儿童服用。可加快术后康复、温经散寒、强筋活血、通络止痛效果,是神经外科术后康复特效中药,多年来在临床应用,治愈患者数百例,疗效显著可靠,药性平和,未出现毒副作用,有效率达95%,治愈率85%。
具体实施方式
实施例1:一种内服外敷用于促进神经外科术后康复的儿童中药,包括内服药物和外敷药物;
内服药物按下列和重量的中药原料组成:甘草35克、薄荷15克、肿节风20克、刘寄奴15克、没药10克、红花20克、丹参15克、地黄20克、白芷20克、延胡索10克、蜂房35克、蒲公英20克、皂角刺20克、忍冬藤40克、醋150克、花生150克、蛋清40克、香兰素0.05克以及白砂糖30克;
外敷药物按下列和重量的中药原料组成:肿节风20克、刘寄奴15克、没药10克、红花20克、延胡索10克、北沙参35克、川芎20克、柴胡20克、冰片40克、醋150克。
实施例2:
一种内服外敷用于促进神经外科术后康复的儿童中药,包括内服药物和外敷药物;
内服药物按下列和重量的中药原料组成:甘草50克、薄荷30克、肿节风45克、刘寄奴30克、没药25克、红花45克、丹参27克、地黄40克、白芷45克、延胡索25克、蜂房50克、蒲公英35克、皂角刺45克、忍冬藤70克、醋200克、花生200克、蛋清80克、香兰素0.1克以及白砂糖60克;
外敷药物按下列和重量的中药原料组成:肿节风45克、刘寄奴30克、没药25克、红花45克、延胡索25克、北沙参50克、川芎35克、柴胡45克、冰片70克、醋200克。
实施例3:一种内服外敷用于促进神经外科术后康复的儿童中药,包括内服药
物和外敷药物:
内服药物按下列和重量的中药原料组成:甘草40克、薄荷20克、肿节风25克、刘寄奴20克、没药15克、红花25克、丹参18克、地黄25克、白芷25克、延胡索15克、蜂房40克、蒲公英25克、皂角刺25克、忍冬藤45克、醋160克、花生160克、蛋清50克、香兰素0.06克以及白砂糖35克;
外敷药物按下列和重量的中药原料组成:肿节风25克、刘寄奴20克、没药15克、红花25克、延胡索15克、北沙参40克、川芎25克、柴胡25克、冰片50克、醋160克。
实施例4:
一种内服外敷用于促进神经外科术后康复的儿童中药,包括内服药物和外敷药物:
内服药物按下列和重量的中药原料组成:甘草45克、薄荷25克、肿节风40克、刘寄奴25克、没药20克、红花40克、丹参24克、地黄35克、白芷40克、延胡索20克、蜂房45克、蒲公英30克、皂角刺40克、忍冬藤65克、醋190克、花生190克、蛋清70克、香兰素0.9克以及白砂糖55克;
外敷药物按下列和重量的中药原料组成:肿节风40克、刘寄奴25克、没药20克、红花40克、延胡索20克、北沙参45克、川芎30克、柴胡40克、冰片60克、醋190克。
实施例5:
一种内服外敷用于促进神经外科术后康复的儿童中药,包括内服药物和外敷药物:
内服药物按下列和重量的中药原料组成:甘草41克、薄荷21克、肿节风30克、刘寄奴21克、没药17克、红花30克、丹参20克、地黄28克、白芷27克、延胡索16克、蜂房41克、蒲公英27克、皂角刺33克、忍冬藤55克、醋170克、花生170克、蛋清60克、香兰素0.07克以及白砂糖40克;
外敷药物按下列和重量的中药原料组成:肿节风30克、刘寄奴21克、没药17克、红花30克、延胡索16克、北沙参41克、川芎26克、柴胡35克、冰片52克、醋170克。
实施例6:
一种内服外敷用于促进神经外科术后康复的儿童中药,包括内服药物和外敷药物:
内服药物按下列和重量的中药原料组成:甘草43克、薄荷23克、肿节风35克、刘寄奴23克、没药19克、红花35克、丹参22克、地黄30克、白芷35克、延胡索18克、蜂房43克、蒲公英29克、皂角刺35克、忍冬藤60克、醋180克、花生180克、蛋清66克、香兰素0.8克以及白砂糖50克;
外敷药物按下列和重量的中药原料组成:肿节风35克、刘寄奴23克、没药19克、红花35克、延胡索18克、北沙参43克、川芎28克、柴胡38克、冰片57克、醋180克。
实施例7:
一种内服外敷用于促进神经外科术后康复的儿童中药,包括内服药物和外敷药物:
内服药物按下列和重量的中药原料组成:甘草42克、薄荷22克、肿节风33克、刘寄奴22克、没药18克、红花33克、丹参21克、地黄29克、白芷32克、延胡索17克、蜂房42克、蒲公英28克、皂角刺34克、忍冬藤57克、醋175克、花生175克、蛋清64克、香兰素0.075克以及白砂糖45克;
外敷药物按下列和重量的中药原料组成:肿节风33克、刘寄奴22克、没药18克、红花33克、延胡索17克、北沙参42克、川芎27克、柴胡36克、冰片55克、醋175克。
根据本发明另一个方面提供,内服药物的制备方法和外敷药物的制备方法:
内服药物的制备方法包括以下步骤:
步骤一:取甘草42克、肿节风33克、没药18克、刘寄奴22克和红花33克混合均匀,加6~9倍量水,加热回流3~4h、蒸馏,收集第一次蒸馏液后,再次蒸馏1~2h,收集第二次蒸馏液后,合并第一次蒸馏液和第二次蒸馏液,提取挥发油,得到挥发油;
步骤二:取丹参21克、地黄29克、白芷32克和蒲公英28克混合均匀,加6~8倍量水微沸煎煮1~2h,滤过,滤渣再加3~6倍量水微沸煎煮40~60min,滤过,合并滤液,提取滤液,得到第一滤液;
步骤三:取皂角刺34克、忍冬藤57克和薄荷22克混合均匀,粉碎成粗粉,按渗漉法制备,用50~70%乙醇作溶剂,浸渍20~35h后,缓缓渗漉,待有效成分完全漉出,收集漉液,回收乙醇,提取漉液,得到第一漉液;
步骤四:取延胡索17克及醋175克,将醋中加入水后,加入延胡索烫至微沸,滤过,提取滤液,得第二滤液;
步骤五:合并步骤二中提取的第一滤液、步骤三中提取的第一漉液以及步骤四中提取的第二滤液,静置8~10h,滤过,放置温度至15~20℃,加入步骤一中提取的挥发油,加入2~4倍量的水,搅匀,得到第一混合物;
步骤六:取蛋清64克、白砂糖45克及蜂房42克放入锅里,加热搅拌,一直搅拌到变为浆为止,制成糖浆;步骤七:将步骤五中得到的第一混合物放入步骤六中制成的糖浆中搅拌均匀成为第二混合物;将第二混合物中加入香兰素0.075克,混合均匀,得到第三混合物;
步骤八:取花生175克倒入步骤七中制得的第三混合物中,搅拌至第三混合物包裹在花生175克外皮上,继续搅拌,直到温度变凉,得到成品;
外敷药物的制备方法包括以下步骤:
步骤一:分别粉碎,再和北沙参42克、川芎27克、柴胡36克、冰片55克一起放入1650ml质量浓度为50%以上的乙醇中浸泡15天,过滤,得乙醇提取液;
步骤二:药渣再加水2200ml,煎煮1h,过滤,得水煎液,浓缩至160ml,制的第一滤液;
步骤三:取延胡索17克及醋175克,将醋175克中加入水后,加入延胡索烫至微沸,滤过,提取滤液,得第二滤液;
步骤四:混合步骤一中制得的乙醇提取液、步骤二中制得的第一滤液以及步骤三中制得的第二滤液,混合均匀,再加热浓缩至220ml,得中药浸膏;
步骤五:将肿节风33克、刘寄奴22克、没药18克、红花33克分别粉碎,混合成中药粉,将步骤四中制得的中药浸膏加入中药粉中,拌匀,摊在贴布上切成小块即成中药贴;每贴为5×5cm的贴布上摊有6ml中药浸膏和3g中药粉,制的成品。
本发明提供的一种内服外敷用于促进神经外科术后康复的儿童中药,选用多种对神经外科术后康复有针对性成分的中药起相互协同作用,同时加入花生、香兰素为辅料,更有利于儿童服用。可加快术后康复、温经散寒、强筋活血、通络止痛效果,是神经外科术后康复特效中药,多年来在临床应用,治愈患者数百例,疗效显著可靠,药性平和,未出现毒副作用,有效率达95%,治愈率85%。发明药物合理,制备方法多样,既可简易加工又适合工厂化生产,工艺简单,且药源广,成本低,服用方便,疗效好,药性平和,无任何毒副作用,特别适合儿童服用。
中药的临床疗效总结:
一、一般资料:本发明一种内服外敷用于促进神经外科术后康复的儿童
中药,选用多种对神经外科术后康复有针对性成分的中药起相互协同作用,同时加入花生、香兰素为辅料,更有利于儿童服用。选用生花生,不经过煎炸等工序,得以有效的保持花生中的营养成分,且花生是儿童喜欢的食品,花生果实含有蛋白质、脂肪、糖类、维生素A、维生素B6、维生素E、维生素K,以及矿物质钙、磷、铁等营养成分,含有8种人体所需的氨基酸及不饱和脂肪酸,含卵磷脂、胆碱、胡萝卜素、粗纤维等物质。脂肪含量为44%~45%,蛋白质含量为24~36%,含糖量为20%左右。含有丰富的维生素B2、PP、A、天、E,钙和铁等。并含有硫胺素、核黄素、尼克酸等多种维生素。有促进儿童的脑细胞发育,增强记忆的作用。选用香兰素作为辅料,去除中药的苦涩以及难闻味道,增加香味有利于儿童食用。
二、毒性实验取小鼠50只(由南京市实验动物和动物实验中心提供),雌性各半,体重20~22g,在人工照明12h、通风良好情况下饲养观察3天,随机分成5组,10只/组,其中1组小白鼠为空白对照组,另外三组分别灌服本发明制备的中药,灌服方法均为将中药溶解在蒸馏水中,加热至30℃~40℃,搅拌完全溶解,灌服量均为15000mg/kg,给药前18h和给药后4h内禁食,但不禁水,观察动物的中毒症状,剖解,观察各组织器官的变化并取心、肝、脾、肾、肺及肠做病理切片,计算半数致死量,连续观察7天,并作记录。用灌胃针口服灌入中药组合物后,个别小鼠蜷缩在角落,活动减少,但第2天观察,40只小鼠活动、饮水和采食均正常。连续观察7天后,40只小鼠均健活。全部小鼠的精神、食欲、肤色、分泌物、眼、呼吸、肌肉运动等方面,均未观察到异常变化,试验结束时捕杀小鼠,肉眼观察脏器变化,与空白对照组的10只小鼠无明显眼观不同。按照毒理学评价标准,属无毒性物质,而本试验口服剂量增加到了15000mg/kg,40只小鼠仍健活,说明中药组合物合剂对小鼠安全无毒。
长期毒性实验
选取豚鼠50只(由南京市实验动物和动物实验中心提供)雌雄各半,体重为250g~300g,分为五组,每组10只,其中1组小白鼠为空白对照组,剩余四组分别灌服本发明制备的中药,灌服量为400mg·kg-1,每日灌服3次,灌服方法均为将中药溶解在蒸馏水中,加热至30℃~40℃,搅拌完全溶解,灌服量均为15000mg/kg,给药前18h和给药后4h内禁食,但不禁水,连续给药90日,观察动物的生长发育、行为活动,进食进水,呼吸,体温,血尿常规,肝肾功能以及其他反应,末次给药后,取血化验,处死动物后肉眼尸检并对心、肝、脾、肺、肾等主要器官进行病理切片检查,用药90日未见实验动物以上各项观察指标没有出现异常改变,或动物死亡,与对照组无明显眼观不同,动物进行解剖并作各脏器组织学检查,均未见异常病理学改变。
皮肤过敏实验
选取豚鼠30只(由南京市实验动物和动物实验中心提供),雌雄各半,体重为250g~300g,将豚鼠固定,剔除体表3×3cm的被毛,分别外涂本发明制备的中药外敷,每日3次,连续使用7日,时间结果表明,皮肤过敏实验为阴性,证明本发明的滴鼻液不会产生过敏性。
临床资料
一、患者资料成人病例:
1、病例选择:
选取神经外科手术患者80例,男43例,女37例,年龄35-65岁,其中脑周围神经手术42例,急诊外伤修复38例。分为对照组40例和治疗组40例,两组患者治疗前在性别、年龄、病情、手术时间上比较,差异无统计学意义,具有可比性。
2、治疗用药:术后一周内,治疗组患者服用本发明药物,每次200~300ml,早晚各一次;外敷本发明的药物膏药,每次一片,早晚各一次。
对照组服用谷维素,20mg/次,3次/天,温水送服。疼痛强度:由患者本人判断,0~10数字疼痛强度分级法(NPIS),记录0~2为无疼痛,3~5为轻度疼痛,6~7为中度疼痛,8~10为重度疼痛。疼痛缓解度:由医生根据患者疼痛减轻程度按5级判断记录。0度,未缓解;1度:轻度缓解(疼痛减轻约为1/4);2度:中度缓解(疼痛减轻约为1/2);3度:明显缓解(疼痛减轻为3/4以上);4度:疼痛消失。
3、疗效判断:外科手术后,伤口可能出现渗血渗液,头痛、呕吐,不同程度的切口疼痛。
用药后两组康复情况比较:治疗组:创面结痂时间5±0.5天对照组:创面结痂时间7±1天。
儿童病例:
1、病例选择:
选取神经外科手术患者60例,男33例,女27例,年龄5-15岁,其中脑周围神经手术32例,急诊外伤修复28例。分为对照组30例和治疗组30例,两组患者治疗前在性别、年龄、病情、手术时间上比较,差异无统计学意义,具有可比性。
2、治疗用药:
术后一周内,治疗组患者服用本发明药物,每次100~200ml,早晚各一次;外敷本发明的药物膏药,每次一片,早晚各一次。对照组服用谷维素,10mg/次,3次/天,温水送服。
疼痛强度:由患者本人判断,0~10数字疼痛强度分级法(NPIS),记录0~2为无疼痛,3~5为轻度疼痛,6~7为中度疼痛,8~10为重度疼痛。疼痛缓解度:由医生根据患者疼痛减轻程度按5级判断记录。0度,未缓解;1度:轻度缓解(疼痛减轻约为1/4);2度:中度缓解(疼痛减轻约为1/2);3度:明显缓解(疼痛减轻为3/4以上);4度:疼痛消失。
3、疗效判断:外科手术后,伤口可能出现渗血渗液,头痛、呕吐,不同程度的切口疼痛。用药后两组康复情况比较:治疗组:创面结痂时间4±0.5天对照组:创面结痂时间10±1天。
根据上述实验可知:治疗组在总有效率方面明显高于对照组,而且针对儿童的治疗效果明显好于对照组的治疗恢复效果,恢复时间快了2倍之多,而且在给儿童服用过程中,儿童十分乐意服用,很大程度上的降低了患者的痛苦,使得儿童患者心情愉悦,更有利于术后的恢复,从而证明本发明的中药组合物在促进神经外科术后康复方面具有显著的效果。且于实验者沟通后,发现儿童服用本发明中药,不仅没有抵触情绪,反而乐于服用,因为花生是大多数儿童喜爱的食物,而且加入香兰素,降低药物的苦涩和中药味,而且加入的香兰素严格按照国家使用比例,十分的安全可靠,本发明不仅大大增加了病患服用药物的痛苦,而且还能有效促进神经外科术后康复,经长期观察本发明有效率达95%,治愈率85%,特别适合儿童服用。
而且经过对比各各实施例,经过长期的临床实验得出,采用实施例7,一种内服外敷用于促进神经外科术后康复的儿童中药,包括内服药物和外敷药物:
内服药物按下列和重量的中药原料组成:甘草42克、薄荷22克、肿节风33克、刘寄奴22克、没药18克、红花33克、丹参21克、地黄29克、白芷32克、延胡索17克、蜂房42克、蒲公英28克、皂角刺34克、忍冬藤57克、醋175克、花生175克、蛋清64克、香兰素0.075克以及白砂糖45克;
外敷药物按下列和重量的中药原料组成:肿节风33克、刘寄奴22克、没药18克、红花33克、延胡索17克、北沙参42克、川芎27克、柴胡36克、冰片55克、醋175克。
效果明显好于其他实施例,效果可以提升10%-20%以上,可以达到更好的愈合效果。创面结痂时间3±0.5天,效果非常好。
以上所述仅是本发明的优选方式,应当指出,对于本领域普通技术人员来说,在不脱离本发明创造构思的前提下,还可以做出若干相似的变形和改进,这些也应视为本发明的保护范围之内。
Claims (5)
1.一种内服外敷用于促进神经外科术后康复的儿童中药,其特征是,包括内服药物和外敷药物;
所述内服药物按下列和重量的中药原料组成:甘草35~50克、薄荷15~30克、肿节风20~45克、刘寄奴15~30克、没药10~25克、红花20~45克、丹参15~27克、地黄20~40克、白芷20~45克、延胡索10~25克、蜂房35~50克、蒲公英20~35克、皂角刺20~45克、忍冬藤40~70克、醋150~200克、花生150~200克、蛋清40~80克、香兰素0.05-0.1克以及白砂糖30~60克;
所述外敷药物按下列和重量的中药原料组成:肿节风20~45克、刘寄奴15~30克、没药10~25克、红花20~45克、延胡索10~25克、北沙参35~50克、川芎20~35克、柴胡20~45克、冰片40~70克、醋150~200克。
2.根据权利要求1所述一种内服外敷用于促进神经外科术后康复的儿童中药,其特征是,包括内服药物和外敷药物;
所述内服药物按下列和重量的中药原料组成:甘草40~45克、薄荷20~25克、肿节风25~40克、刘寄奴20~25克、没药15~20克、红花25~40克、丹参18~24克、地黄25~35克、白芷25~40克、延胡索15~20克、蜂房40~45克、蒲公英25~30克、皂角刺25~40克、忍冬藤45~65克、醋160~190克、花生160~190克、蛋清50~70克、香兰素0.06-0.9克以及白砂糖35~55克;
所述外敷药物按下列和重量的中药原料组成:肿节风25~40克、刘寄奴20~25克、没药15~20克、红花25~40克、延胡索15~20克、北沙参40~45克、川芎25~30克、柴胡25~40克、冰片50~60克、醋160~190克。
3.根据权利要求1所述一种内服外敷用于促进神经外科术后康复的儿童中药,其特征是,包括内服药物和外敷药物;
所述内服药物按下列和重量的中药原料组成:甘草41~43克、薄荷21~23克、肿节风30~35克、刘寄奴21~23克、没药17~19克、红花30~35克、丹参20~22克、地黄28~30克、白芷27~35克、延胡索16~18克、蜂房41~43克、蒲公英27~29克、皂角刺33~35克、忍冬藤55~60克、醋170~180克、花生170~180克、蛋清60~66克、香兰素0.07-0.8克以及白砂糖40~50克;
所述外敷药物按下列和重量的中药原料组成:肿节风30~35克、刘寄奴21~23克、没药17~19克、红花30~35克、延胡索16~18克、北沙参41~43克、川芎26~28克、柴胡35~38克、冰片52~57克、醋170~180克。
4.根据权利要求1所述一种内服外敷用于促进神经外科术后康复的儿童中药,其特征是,包括内服药物和外敷药物;
所述内服药物按下列和重量的中药原料组成:甘草42克、薄荷22克、肿节风33克、刘寄奴22克、没药18克、红花33克、丹参21克、地黄29克、白芷32克、延胡索17克、蜂房42克、蒲公英28克、皂角刺34克、忍冬藤57克、醋175克、花生175克、蛋清64克、香兰素0.075克以及白砂糖45克;
所述外敷药物按下列和重量的中药原料组成:肿节风33克、刘寄奴22克、没药18克、红花33克、延胡索17克、北沙参42克、川芎27克、柴胡36克、冰片55克、醋175克。
5.根据权利要求1~4任一项所述的一种内服外敷用于促进神经外科术后康复的儿童中药的制备方法,其特征在于包括内服药物的制备方法和外敷药物的制备方法:
所述内服药物的制备方法包括以下步骤:
步骤一:取甘草、肿节风、没药、刘寄奴和红花混合均匀,加6~9倍量水,加热回流3~4h、蒸馏,收集第一次蒸馏液后,再次蒸馏1~2h,收集第二次蒸馏液后,合并第一次蒸馏液和第二次蒸馏液,提取挥发油,得到挥发油;
步骤二:取丹参、地黄、白芷和蒲公英混合均匀,加6~8倍量水微沸煎煮1~2h,滤过,滤渣再加3~6倍量水微沸煎煮40~60min,滤过,合并滤液,提取滤液,得到第一滤液;
步骤三:取皂角刺、忍冬藤和薄荷混合均匀,粉碎成粗粉,按渗漉法制备,用50~70%乙醇作溶剂,浸渍20~35h后,缓缓渗漉,待有效成分完全漉出,收集漉液,回收乙醇,提取漉液,得到第一漉液;
步骤四:取延胡索及醋,将醋中加入水后,加入延胡索烫至微沸,滤过,提取滤液,得第二滤液;
步骤五:合并步骤二中提取的所述第一滤液、步骤三中提取的所述第一漉液以及步骤四中提取的所述第二滤液,静置8~10h,滤过,放置温度至15~20℃,加入步骤一中提取的所述挥发油,加入2~4倍量的水,搅匀,得到第一混合物;
步骤六:取蛋清、白砂糖及蜂房放入锅里,加热搅拌,一直搅拌到变为浆为止,制成糖浆;
步骤七:将步骤五中得到的所述第一混合物放入步骤六中制成的所述糖浆中搅拌均匀成为第二混合物;将所述第二混合物中加入香兰素,混合均匀,得到第三混合物;
步骤八:取花生倒入步骤七中制得的所述第三混合物中,搅拌至所述第三混合物包裹在所述花生外皮上,继续搅拌,直到温度变凉,得到成品;
所述外敷药物的制备方法包括以下步骤:
步骤一:分别粉碎,再和北沙参、川芎、柴胡、冰片一起放入1650ml质量浓度为50%以上的乙醇中浸泡15天,过滤,得乙醇提取液;
步骤二:药渣再加水2200ml,煎煮1h,过滤,得水煎液,浓缩至160ml,制的第一滤液;
步骤三:取延胡索及醋,将醋中加入水后,加入延胡索烫至微沸,滤过,提取滤液,得第二滤液;
步骤四:混合步骤一中制得的所述乙醇提取液、步骤二中制得的第一滤液以及步骤三中制得的第二滤液,混合均匀,再加热浓缩至220ml,得中药浸膏;
步骤五:将肿节风、刘寄奴、没药、红花分别粉碎,混合成中药粉,将步骤四中制得的所述中药浸膏加入所述中药粉中,拌匀,摊在贴布上切成小块即成中药贴;每贴为5×5cm的贴布上摊有6ml所述中药浸膏和3g所述中药粉,制的成品。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2016102748389 | 2016-04-28 | ||
CN201610274838.9A CN105853575A (zh) | 2016-04-28 | 2016-04-28 | 一种内服外敷用于促进神经外科术后康复的儿童中药配方 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106389651A true CN106389651A (zh) | 2017-02-15 |
Family
ID=56628729
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610274838.9A Pending CN105853575A (zh) | 2016-04-28 | 2016-04-28 | 一种内服外敷用于促进神经外科术后康复的儿童中药配方 |
CN201611078822.7A Pending CN106389651A (zh) | 2016-04-28 | 2016-11-30 | 一种内服外敷用于促进神经外科术后康复的儿童中药 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610274838.9A Pending CN105853575A (zh) | 2016-04-28 | 2016-04-28 | 一种内服外敷用于促进神经外科术后康复的儿童中药配方 |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN105853575A (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106421393A (zh) * | 2016-11-03 | 2017-02-22 | 何元奎 | 一种促进神经外科术后康复的中药 |
CN108272898A (zh) * | 2018-04-03 | 2018-07-13 | 冯斌 | 一种神经外科术后康复用药物 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103330906A (zh) * | 2012-02-22 | 2013-10-02 | 高乃福 | 一种消肿药酒 |
CN104547239A (zh) * | 2015-01-01 | 2015-04-29 | 任毅 | 一种治疗鼻窦炎的儿童中药配方 |
CN104857262A (zh) * | 2015-05-19 | 2015-08-26 | 侯子义 | 治疗刀伤疮伤及术后化脓性感染的纯中药制剂 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102861208B (zh) * | 2012-09-19 | 2014-02-19 | 王吉坤 | 一种用于抗菌消炎、抗病毒的中药复方 |
-
2016
- 2016-04-28 CN CN201610274838.9A patent/CN105853575A/zh active Pending
- 2016-11-30 CN CN201611078822.7A patent/CN106389651A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103330906A (zh) * | 2012-02-22 | 2013-10-02 | 高乃福 | 一种消肿药酒 |
CN104547239A (zh) * | 2015-01-01 | 2015-04-29 | 任毅 | 一种治疗鼻窦炎的儿童中药配方 |
CN104857262A (zh) * | 2015-05-19 | 2015-08-26 | 侯子义 | 治疗刀伤疮伤及术后化脓性感染的纯中药制剂 |
Also Published As
Publication number | Publication date |
---|---|
CN105853575A (zh) | 2016-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE19953829C2 (de) | Nasenspray (-Tropfen) zur Behandlung von Fieber, Erkältung sowie seine Herstellung | |
US9554985B2 (en) | Agent for promoting hair growth and method for preparing same | |
CN105076894A (zh) | 一种奶牛配合饲料及其制备方法 | |
CN103239662A (zh) | 兽用驱虫中药制剂 | |
CN106389651A (zh) | 一种内服外敷用于促进神经外科术后康复的儿童中药 | |
CN102772712A (zh) | 一种治疗热毒炽盛血瘀型糖尿病足的中药组合物 | |
CN104857366A (zh) | 一种神经外科术前干预药物组合物及其应用 | |
CN102283976B (zh) | 一种治疗癌症的药物 | |
CN104352793A (zh) | 一种治疗消化道出血的中药制剂及其制备方法 | |
DE202004018534U1 (de) | Kräuterzusammensetzung zur Vermeidung und/oder Behandlung von Zuständen in Verbindung mit Depression | |
CN109172346B (zh) | 一种糖尿病人用的足浴盆 | |
CN104474404A (zh) | 一种防治免疫缺陷患者感染的复方栓剂 | |
CN103520684B (zh) | 一种降血糖的中药复合物 | |
CN105963498A (zh) | 一种用于术后康复的中药组合物及其制备方法 | |
CN104839483A (zh) | 一种2-3龄鳖的配合饲料及其制备方法 | |
CN104223062B (zh) | 一种降压降糖的地骨皮保健口服液及其制备方法 | |
CN106729327A (zh) | 一种治疗气血两虚兼肾虚型月经不调的中药组合物 | |
CN105288131A (zh) | 一种治疗肾结核的中药汤剂及其制备方法 | |
CN106362024A (zh) | 一种用于促进风湿康复的中老年人中药配方 | |
CN105326948A (zh) | 一种制备治疗三叉神经痛的中药制剂的方法 | |
CN105770115A (zh) | 一种治疗湿疹的中药药膏 | |
CN105267349A (zh) | 一种治疗三叉神经痛的中药制剂 | |
CN105012847A (zh) | 一种保胎安固的中药 | |
CN104940561A (zh) | 一种治疗眼疾的中药制剂及其制备方法 | |
CN106266205A (zh) | 一种用于促进糖尿病足康复的中老年人中药配方 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170215 |
|
RJ01 | Rejection of invention patent application after publication |